Company · CIK 1671858
ARS Pharmaceuticals, Inc.
| CIK | 1671858 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | SPRY (Nasdaq) |
| First annual or quarterly report | 2021-03-29 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-284650 | 2025-01-31 | 2025-01-31 | 1 | |
| 333-271359 | 2023-04-20 | 2023-05-03 | 2 | |
| 333-261979 | 2022-01-03 | 2022-01-13 | 2 | |
| 333-250009 | 2020-11-10 | 2020-12-04 | 5 |
Filings
11| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2025-01-31 | S-3ASRShelf registered | 333-284650 | 0001193125-25-018480 |
| 2023-05-03 | EFFECTDeclared effective | 333-271359 | 9999999995-23-001273 |
| 2023-04-20 | S-3Shelf registered | 333-271359 | 0001193125-23-108478 |
| 2022-01-13 | EFFECTDeclared effective | 333-261979 | 9999999995-22-000139 |
| 2022-01-03 | S-3Shelf registered | 333-261979 | 0001193125-22-000630 |
| 2020-12-04 | 424B4Final prospectus | 333-250009 | 0001193125-20-310601 |
| 2020-12-03 | EFFECTDeclared effective | 333-250009 | 9999999995-20-003391 |
| 2020-12-03 | S-1/AAmendment | 333-250009 | 0001193125-20-308867 |
| 2020-11-30 | S-1/AAmendment | 333-250009 | 0001193125-20-304858 |
| 2020-11-10 | S-1Registration filed | 333-250009 | 0001193125-20-290236 |
| 2020-10-02 | DRSDraft made public | 377-03623 | 0000950123-20-010063 |